Has Benjamin Guevara, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,370 in general payments to Benjamin Guevara, MD across 291 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benjamin Guevara, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benjamin Guevara, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benjamin Guevara, MD

Sports Medicine · Slidell, LANPI 1679797385

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,188 of the $19,370 with a category attached, or 62.9%. 19 manufacturers reported payments, led by Stryker at 59.7% of the total. Reporting peaked in 2024 at $4,799 and has fallen 74.2% since, to $1,239 in 2025.

$19,370in general payments, 2019–2025

Across 291 payments — averaging $66.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$12K
ALON Medical Technology$3K
Arthrex$2K
Smith+Nephew$1K
Zimmer Biomet$881
Pacira Therapeutics, Inc.$155
plus $332 from 13 others

What the payments were for

Travel & lodging$4,26222%
Food & beverage$12,18863%
Education$2,92015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	223	$11,558
ALON Medical Technology	8	$3,257
Arthrex	21	$2,074
Smith+Nephew	12	$1,113
Zimmer Biomet	10	$881
Pacira Therapeutics, Inc.	3	$155
Siemens Medical Solutions USA, Inc.	1	$66
Omnilife Science, Inc	1	$46
Innovation Technologies Inc	1	$30
Bioventus LLC	1	$29
Pacira Pharmaceuticals Incorporated	2	$27
BREG, Inc	1	$23
Vericel Corporation	1	$23
Ultragenyx Pharmaceutical Inc.	1	$22
Sonex Health, Inc.	1	$14
Vertex	1	$14
Medtronic	1	$14
Argon Medical Devices, Inc.	1	$13
Mallinckrodt Hospital Products Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$1,386
REUNION$1,112
TRIATHLON$912
TRITANIUM$764
Endobutton$536
Mini-Open Latarjet$536
Bioinductive Implant with Arthroscopic Delivery System - Medium$536
Juggerknot$530
AEQUALIS PERFORM$190
ALPHAVENT$164
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$151
GAMMA$126
Zilretta$115
SHOULDER IMPLANTS FIBERTAK KNOTLESS$115

How this compares

$19,370 in reported general payments places this provider in the 80th percentile of 82 sports medicine providers in Louisiana.

See all sports medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$181,725

Medicare patients

474

Services billed

1,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	294	$2,216
Celecoxib	111	$1,073
Tramadol Hcl	82	$1,048
Ondansetron Hcl	160	$1,020
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	128	$977
Ibuprofen	148	$759
Cyclobenzaprine Hcl	226	$687
Diclofenac Sodium	25	$636
Meloxicam	137	$344
Gabapentin	28	$265
Ondansetron OdtOndansetron	16	$257
Methylprednisolone	23	$130
Amoxicillin	11	$20

Paid to pharmacies, not to this prescriber.